feed,title,long_url,short_url
GN:S:RL,Insilico Announces Successful Completion of Phase 0 Microdose Trial and Initiates Phase I Clinical Trial for its First AI-discovered Anti-fibrotic Product Candidate with Novel Target - PRNewswire,https://www.prnewswire.com/news-releases/insilico-announces-successful-completion-of-phase-0-microdose-trial-and-initiates-phase-i-clinical-trial-for-its-first-ai-discovered-anti-fibrotic-product-candidate-with-novel-target-301489534.html,https://prn.to/3JXbTBn
